查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585620

生物膜治療市場：按產品類型、傷口類型、最終用戶分類 - 全球預測 2025-2030

Biofilms Treatment Market by Product (Debridement Equipment, Gauzes & Dressings, Gels, Ointments & Sprays), Wound Type (Burns & Open Wounds, Diabetic Foot Ulcers, Pressure Ulcers), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物膜處理市場規模為29.2億美元，預計2024年將達31.8億美元，複合年成長率為9.31%，預計到2030年將達到54.5億美元。

生物膜療法是解決與微生物相關問題的關鍵要素，這些微生物在表面形成結構化群落並抵抗傳統治療。生物膜處理的需求源於與各種慢性感染疾病、工業系統的維護以及海洋環境中的生物污垢的關係。應用範圍從醫療保健（生物膜導致醫療設備感染疾病）到工業環境（生物膜對抗管道中的腐蝕和效率問題）。最終用途領域包括醫療設備製造商、製藥、水處理設施、食品加工業以及海洋和石油工業。

主要市場統計
基準年[2023] 29.2億美元
預測年份 [2024] 31.8億美元
預測年份 [2030] 54.5億美元
複合年成長率（%） 9.31%

人們對生物膜相關挑戰的認知不斷提高、抗菌素抗藥性研究的進展以及創新生物膜治療研究的激增正在推動市場成長。對醫療保健的需求不斷成長和嚴格的法律規範進一步提振了市場。最新的商機在於開發有針對性的抗菌治療、永續的化學替代品以及抗生物膜形成的先進材料。生物技術和製藥投資的激增為創新提供了肥沃的土壤，特別是在開發抑制植入和工業系統上生物膜生長的精密材料方面。然而，高昂的開發成本、潛在的監管障礙以及生物膜根除的複雜性正在限制新興市場的成長。另一個挑戰是，在出現嚴重問題之前很難診斷生物膜的存在。

未來的研究和創新可以集中在基於奈米顆粒的治療、抗生物膜表面塗層和微生物干擾療法。學術界、工業界和監管機構之間的合作可以帶來個人化醫療和永續工業實踐的突破。了解多種治療方法的協同效應也可能提供全面的解決方案。由於技術進步和環境法規，市場正在發生動態變化，凸顯了策略規劃中敏捷性和適應性的重要性。對於尋求擴張或投資的公司來說，專注於產品開發的綜合和跨學科方法可以確保競爭優勢並滿足醫療保健和各個行業領域的新興需求。

市場動態：揭示快速發展的生物膜處理市場的關鍵市場洞察

供需的動態交互作用正在改變生物膜處理市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 手術傷口和外傷的發生率增加
    • 全球燒燙傷和傷口發生率增加
    • 糖尿病人口不斷增加以及對糖尿病足潰瘍有效治療方法的需求
  • 市場限制因素
    • 與生物膜處理相關的結構複雜性
  • 市場機會
    • 生物膜處理技術不斷進步
    • 策略聯盟與投資擴大生物膜感染研究
  • 市場挑戰
    • 對生物膜相關細菌抗菌素抗藥性的擔憂

波特五力：駕馭生物膜治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物膜處理市場的外部影響

外部宏觀環境因素在塑造生物膜處理市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解生物膜處理市場的競爭格局

對生物膜處理市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位基質生物膜治療市場供應商績效評估

FPNV定位矩陣是評估生物膜處理市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了生物膜處理市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對生物膜處理市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 外科性創傷和創傷的發生率增加
      • 全球燒燙傷和創傷發生率增加
      • 糖尿病患者數量不斷增加以及對糖尿病足潰瘍有效治療的需求
    • 抑制因素
      • 與生物膜處理相關的結構複雜性
    • 機會
      • 生物膜處理技術不斷進步
      • 策略聯盟與投資擴大生物膜感染疾病研究
    • 任務
      • 對生物膜相關生物體抗菌素抗藥性的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生物膜處理市場：依產品

  • 清創裝置
  • 紗布和敷料
  • 凝膠、軟膏、噴霧劑
  • 移植物和基質
  • 擦拭巾、墊片和清潔溶液

第7章依傷口類型分類的生物膜治療市場

  • 燒燙傷和開放性傷口
  • 糖尿病足潰瘍
  • 褥瘡
  • 外傷及外科性創傷
  • 腿部靜脈性潰瘍

第8章生物膜處理市場：依最終使用者分類

  • 家庭護理設置
  • 醫院、ASC、創傷護理中心

第9章美洲生物膜處理市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太生物膜處理市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲生物膜處理市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Innoviva 肺炎抗生素獲得 FDA核准
    • TVM Capital Healthcare 宣布向 DEBx Medical 投資 1,000 萬歐元
    • BlastX 抗菌生物膜傷口凝膠在澳洲推出
  • 戰略分析和建議

公司名單

  • 3M Company
  • Aroa Biosurgery, Ltd
  • Arobella Medical, LLC
  • Avery Dennison Corporation
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Coloplast A/S
  • ConvaTec Group PLC
  • DEBx Medical BV
  • Ecolab Inc.
  • Essity AB
  • Garwood Medical Devices, LLC
  • Integra LifeSciences Corporation
  • Kane Biotech Inc.
  • Medaxis AG
  • Mediq BV
  • Medline Industries, LP
  • Mil Laboratories Pvt. Ltd.
  • MIMEDX Group, Inc.
  • Molnlycke Health Care AB
  • Next Science Ltd.
  • Organogenesis Inc.
  • Paul Hartmann AG
  • Pulsecare Medical LLC
  • RLS Global AB
  • Sanara MedTech Inc.
  • Smith & Nephew PLC
  • Zimmer Biomet
Product Code: MRR-F949FCDE09F4

The Biofilms Treatment Market was valued at USD 2.92 billion in 2023, expected to reach USD 3.18 billion in 2024, and is projected to grow at a CAGR of 9.31%, to USD 5.45 billion by 2030.

Biofilm treatment is a critical component in addressing issues related to microorganisms that form structured communities on surfaces and resist conventional treatments. The necessity for biofilm treatment emerges from its involvement in various chronic infections, industrial systems maintenance, and biofouling in marine environments. Applications span across healthcare, where biofilms contribute to infections on medical devices, to industrial settings dealing with pipeline corrosion and efficiency impediments. End-use sectors include medical device manufacturers, pharmaceuticals, water treatment facilities, food processing industries, and marine and oil industries.

KEY MARKET STATISTICS
Base Year [2023] USD 2.92 billion
Estimated Year [2024] USD 3.18 billion
Forecast Year [2030] USD 5.45 billion
CAGR (%) 9.31%

Market growth is driven by increasing awareness of biofilm-related challenges, advances in antimicrobial resistance studies, and a surge in research on innovative biofilm treatments. Rising healthcare demands and stringent regulatory frameworks further propel the market. The latest opportunities lie in developing targeted antimicrobial treatments, sustainable chemical alternatives, and advanced materials resistant to biofilm formation. The surge in biotechnology and pharmaceutical investments offers fertile ground for innovation, especially in developing precision materials that deter biofilm growth on implants and industrial systems. However, market growth faces limitations due to high development costs, potential regulatory hurdles, and the complex nature of biofilm eradication. Difficulty in diagnosing biofilm presence until significant issues arise also poses challenges.

Future research and innovation can focus on nanoparticle-based treatments, biofilm-resistant surface coatings, and microbial interference therapy. Collaborations between academia, industry, and regulations could lead to breakthroughs in personalized medicine and sustainable industrial practices. Understanding the synergistic effects of multiple treatment modalities could also offer comprehensive solutions. The market is dynamic, driven by technological advancements and environmental regulations, emphasizing the importance of agility and adaptation in strategic planning. For businesses looking to expand or invest, focusing on integrated and multi-disciplinary approaches in product development can ensure competitive advantage and meet emerging needs in healthcare and various industrial sectors.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biofilms Treatment Market

The Biofilms Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of surgical and traumatic wounds
    • Rising incidence of burn injuries and wounds worldwide
    • Increasing diabetic population and need for efficient tretamnet of diabetic foot ulcer
  • Market Restraints
    • Structural complexity associated with biofilm treatment
  • Market Opportunities
    • Ongoing advancement in biofilms treatment technologies
    • Strategic alliances and investments to expand reserach on biofilm infections
  • Market Challenges
    • Concerns related to the resistance of biofilm-associated organisms to antimicrobial agents

Porter's Five Forces: A Strategic Tool for Navigating the Biofilms Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biofilms Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biofilms Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biofilms Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biofilms Treatment Market

A detailed market share analysis in the Biofilms Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biofilms Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biofilms Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biofilms Treatment Market

A strategic analysis of the Biofilms Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biofilms Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Aroa Biosurgery, Ltd, Arobella Medical, LLC, Avery Dennison Corporation, B. Braun Melsungen AG, Cardinal Health, Inc., Coloplast A/S, ConvaTec Group PLC, DEBx Medical BV, Ecolab Inc., Essity AB, Garwood Medical Devices, LLC, Integra LifeSciences Corporation, Kane Biotech Inc., Medaxis AG, Mediq B.V., Medline Industries, LP, Mil Laboratories Pvt. Ltd., MIMEDX Group, Inc., Molnlycke Health Care AB, Next Science Ltd., Organogenesis Inc., Paul Hartmann AG, Pulsecare Medical LLC, RLS Global AB, Sanara MedTech Inc., Smith & Nephew PLC, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Biofilms Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Debridement Equipment, Gauzes & Dressings, Gels, Ointments & Sprays, Grafts & Matrices, and Wipes, Pads & Lavage Solutions.
  • Based on Wound Type, market is studied across Burns & Open Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Traumatic & Surgical Wounds, and Venous Leg Ulcers.
  • Based on End User, market is studied across Home Care Settings and Hospitals, ASCs & Wound Care Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of surgical and traumatic wounds
      • 5.1.1.2. Rising incidence of burn injuries and wounds worldwide
      • 5.1.1.3. Increasing diabetic population and need for efficient tretamnet of diabetic foot ulcer
    • 5.1.2. Restraints
      • 5.1.2.1. Structural complexity associated with biofilm treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancement in biofilms treatment technologies
      • 5.1.3.2. Strategic alliances and investments to expand reserach on biofilm infections
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to the resistance of biofilm-associated organisms to antimicrobial agents
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biofilms Treatment Market, by Product

  • 6.1. Introduction
  • 6.2. Debridement Equipment
  • 6.3. Gauzes & Dressings
  • 6.4. Gels, Ointments & Sprays
  • 6.5. Grafts & Matrices
  • 6.6. Wipes, Pads & Lavage Solutions

7. Biofilms Treatment Market, by Wound Type

  • 7.1. Introduction
  • 7.2. Burns & Open Wounds
  • 7.3. Diabetic Foot Ulcers
  • 7.4. Pressure Ulcers
  • 7.5. Traumatic & Surgical Wounds
  • 7.6. Venous Leg Ulcers

8. Biofilms Treatment Market, by End User

  • 8.1. Introduction
  • 8.2. Home Care Settings
  • 8.3. Hospitals, ASCs & Wound Care Centers

9. Americas Biofilms Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biofilms Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biofilms Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Innoviva gets FDA nod for pneumonia antibiotic
    • 12.3.2. TVM Capital Healthcare announces Euro 10 M investment in DEBx Medical
    • 12.3.3. BlastX Antimicrobial Biofilm Wound Gel Now Available in Australia
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Aroa Biosurgery, Ltd
  • 3. Arobella Medical, LLC
  • 4. Avery Dennison Corporation
  • 5. B. Braun Melsungen AG
  • 6. Cardinal Health, Inc.
  • 7. Coloplast A/S
  • 8. ConvaTec Group PLC
  • 9. DEBx Medical BV
  • 10. Ecolab Inc.
  • 11. Essity AB
  • 12. Garwood Medical Devices, LLC
  • 13. Integra LifeSciences Corporation
  • 14. Kane Biotech Inc.
  • 15. Medaxis AG
  • 16. Mediq B.V.
  • 17. Medline Industries, LP
  • 18. Mil Laboratories Pvt. Ltd.
  • 19. MIMEDX Group, Inc.
  • 20. Molnlycke Health Care AB
  • 21. Next Science Ltd.
  • 22. Organogenesis Inc.
  • 23. Paul Hartmann AG
  • 24. Pulsecare Medical LLC
  • 25. RLS Global AB
  • 26. Sanara MedTech Inc.
  • 27. Smith & Nephew PLC
  • 28. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. BIOFILMS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. BIOFILMS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOFILMS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOFILMS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOFILMS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOFILMS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOFILMS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOFILMS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOFILMS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOFILMS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY DEBRIDEMENT EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY GAUZES & DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY GELS, OINTMENTS & SPRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY GRAFTS & MATRICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY WIPES, PADS & LAVAGE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY BURNS & OPEN WOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY TRAUMATIC & SURGICAL WOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY VENOUS LEG ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOFILMS TREATMENT MARKET SIZE, BY HOSPITALS, ASCS & WOUND CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES BIOFILMS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA BIOFILMS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM BIOFILMS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM BIOFILMS TREATMENT MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM BIOFILMS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. BIOFILMS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. BIOFILMS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023